Pharmafile Logo
Pharmafocus logo
Advanced Search

Frank Morich and Haruhiko Hirate join Takeda

June 30, 2010
Sales and Marketing Takeda, appointment, sales and marketing

Takeda has made new two appointments, looking outside the company to fill a brace of executive-level positions. Dr Frank Morich …

Appointment

Real World Development: Increasing value for patients

June 30, 2010
Research and Development Kinapse, drug development

The traditional drug development paradigm is protracted and costly, with many products failing to deliver commercial or clinical success.We propose …

Feature

Contract research news in brief

June 30, 2010
Research and Development CRO

Yet more geographic expansion from leading CROs, with Kendle opening an office in India and PRA International announcing a Hungarian …

News
Avandia

Avandia probe deepens

June 29, 2010
Sales and Marketing Avandia, GlaxoSmithKline, diabetes

GlaxoSmithKline has come under further scrutiny from the FDA after two new studies showed patients taking its troubled diabetes medication …

News

NHS trials patient payments

June 29, 2010
NHS, PCT, patient

For the first time patients are to be paid directly by the NHS to allow them to choose how their …

News

J&J recall plant will be closed all year

June 29, 2010
Manufacturing and Production Johnson & Johnson, McNeil, manufacturing compliance

The manufacturing facility at the centre of Johnson & Johnson’s product recall woes is likely to stay closed until at …

News

DPT promotes JJ Feik

June 29, 2010
Manufacturing and Production DPT Laboratories, appointment, manufacturing and production

Contract development and manufacturing company DPT Laboratories has promoted JJ Feik to senior director of business development. He was previously …

Appointment
Glivec pack

Higher dose of Glivec not cost effective, says NICE

June 29, 2010
Sales and Marketing Glivec, NICE, gastric cancer

 

News

Chemists find easier method for drug synthesis

June 29, 2010
Manufacturing and Production manufacturing

Researchers in the US have developed a new synthetic pathway that could make the development of new pharmaceuticals quicker, cleaner …

News

Boehringer cheered by diabetes data

June 28, 2010
Research and Development Boehringer, DPP-4, diabetes, linagliptin

Boehringer Ingelheim has been cheered by phase III data showing its new oral once-daily type II diabetes tablet linagliptin significantly …

News

Digital Pharma: The smokescreen of regulation

June 28, 2010
Medical Communications, Sales and Marketing Janssen, social media

When framing a story for the media it is well known in the communications community that a successful piece must …

Feature

European regulator probes ARB cancer link

June 28, 2010
Sales and Marketing ARB, Amias, Aprovel, Cozaar, Diovan, Micardis

European regulators have begun an investigation into a possible risk of cancer in patients taking angiotensin II receptor inhibitors for …

News

Shire’s Vpriv recommended for European approval

June 28, 2010
Sales and Marketing Brinavess, Gaucher, Rapiscan, Ruconest, Shire, Sycrest

Shire has won backing from a key European regulatory committee for its new Gaucher disease orphan drug. Vpriv was one …

News
Claudio_Albrecht_CEO

Actavis appoints Dr Claudio Albrecht

June 28, 2010
Sales and Marketing Actavis, appointment, sales and marketing

Icelandic generics company Actavis has appointed Dr Claudio Albrecht as its new chief executive. He formerly led Ratiopharm and has …

Appointment

New anti-clotting drugs: stopping the silent killers

June 28, 2010
Research and Development, Sales and Marketing Pradaxa, VTE, Xarelto, atrial fibrilation, thrombosis

Blood clots are a major killer, but the threat they pose is poorly understood by the general public compared to …

Feature
Langland

Langland and Dr Foster share top honours at Best of Health

June 25, 2010
Medical Communications, Sales and Marketing Best of Health, IPA, awards

Dr Foster Intelligence and Langland were awarded the most prestigious ‘Best of Show’ awards at the 2010 IPA Best of …

News

Anup Shah joins Woolley Pau PR

June 25, 2010
Medical Communications Woolley Pau, appointment, medical communications

Anup Shah has joined Woolley Pau PR as account director to develop the UK agency’s PR’s medical communication team. He …

Appointment

Sanofi licences novel oral anti-diabetic treatment

June 25, 2010
Research and Development, Sales and Marketing Metabolex, Sanofi-Aventis, diabetes

Sanofi-Aventis has signed an exclusive worldwide licensing agreement with US-based diabetes specialist Metabolex for a novel oral anti-diabetic treatment. MBX-2982 …

News

NICE re-thinks arthritis guidance

June 25, 2010
Sales and Marketing Enbrel, Humira, MabThera, NICE, Orencia, Remicade, TNF, rheumatoid arthritis

NICE has approved five rheumatoid arthritis treatments in certain circumstances after treatment with a tumour necrosis factor inhibitor has failed. …

News
Pfizer iPad app

Digital Pharma: First pharma iPad apps

June 25, 2010
Medical Communications, Sales and Marketing Apple, Pfizer, Sanofi, app, ipad, iphone

The first big pharma apps specially designed for Apple’s iPad have started to emerge, with Pfizer and Sanofi leading the …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026